Learn about early-onset Alzheimer's through real stories of hope and breakthrough treatments that are changing lives of patients diagnosed before age ...
Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...
A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...
Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...
Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...
This groundbreaking finding, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that ...
Eli Lilly ( LLY 1.80%) and Novo Nordisk ( NVO 2.76%) are two of the most valuable healthcare stocks in the world, largely due ...
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...
In July 2024, people living with early Alzheimer’s and organizations such as the Alzheimer’s Association celebrated FDA ...
The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...